Featured News

Media Contact: Stephanie Bulak info@sidp.org

  • 26 Aug 2014 10:01 AM | Christopher McCoy (Administrator)

    Triumeq (ABACAVIR SULFATE;DOLUTEGRAVIR;LAMIVUDINE)

    was approved by the FDA on August 22nd, marking the second once daily integrase combination approved but without the drug interactions and intolerances associated with cobicistat in the QUAD pill.  Information from the SINGLE trial is available from the CROI 2014 meeting and a review of the agent in N Engl J Med. 2013;369:1807-1818.

  • 07 Aug 2014 8:34 AM | Christopher McCoy (Administrator)

    After initial rejection in 2008, Oritavancin is approved today with the gateway indication for acute bacterial skin and skin structure infections (ABSSSI) caused by certain susceptible bacteria, including Staphylococcus aureus (including methicillin-susceptible and methicillin-resistant strains), various Streptococcus species and Enterococcus faecalis.  Oritavancin now joins dalbavancin, approved May 2014 and tedizolid approved June 2014 for similar indications, all with unique profiles.  The data exceeds this space so for more information, you can always review the CDER brief but objective review for dalbavancin and tedizolid. Review papers from the 2000s for oritavancin basics. Three new drugs courtesy of the GAIN act. Looking forward to the new beta lactamase inhibitor and cephalosporin for new gram negative pathogen options.

  • 06 Aug 2014 9:57 AM | Christopher McCoy (Administrator)

    BACK TO THE PATIENT:
    RE-FOCUSING ANTIMICROBIAL
    STEWARDSHIP

    SEPTEMBER 6, 2014
    7:00 AM - 9:00 AM
    MEETING ROOM 206
    WALTER E. WASHINGTON CONVENTION CENTER
    801 MT VERNON PLACE NW
    WASHINGTON, DC


    PRESENTERS
    ANTHONY D. HARRIS, MD, MPH
    Professor of Medicine
    University of Maryland Medical Center, Baltimore, MD

    This session will educate the clinician on how to identify patient centered outcomes to measure the performance of an ASP, including the feasibility of capturing such measures and consideration of the changing healthcare landscape in the era of healthcare reform.


    CRAIG A. MARTIN, PHARMD, BCPS
    Clinical Associate Professor
    Department of Pharmacy Practice and Services
    University of Kentucky College of Pharmacy, Lexington, KY

    This session will inform the clinician on various types of quasiexperimental studies, including the advantages and disadvantages of each type and consideration of variability in resource availability.


    For more information and to register, view the summary.

  • 06 Aug 2014 9:35 AM | Christopher McCoy (Administrator)

    Live CE Webinar
    The Role of Antimicrobial

    Testing and Reporting
    in Antibiotic Stewardship


    Wednesday, August 27, 2014  -  2:00-3:00pm CT

     


    Information derived from antibiotic susceptibility testing (AST) can be a powerful tool in determining appropriate selection, dosing, and duration of antibiotics. The standards for how this testing is performed change on an annual basis and can influence the results that the clinician uses to make treatment determinations.

     

    This session will provide an overview of the current Clinical and Laboratory Standards Institute (CLSI) breakpoints and discuss new concepts such as the addition of the category of “susceptible – dose dependent” or S-DD. The most effective way to utilize AST results and apply them at the bedside will also be discussed. The format for the activity will include examples of laboratory reports and clinician responses to these reports as discussed by the speakers in an interactive format. 

    Live Webinar:  
    August 27, 2014  -  2:00–3:00pm Central Time
    Cost: $25
    (fee waived for SIDP, ACCP ID PRN, and ACCP CRIT PRN Members
    with special code/ check your email for the code)

    For additional information and to register: Click Here

     

    Faculty:

    James S. Lewis II, PharmD, FIDSA

    ID Clinical Pharmacy Coordinator

    & Adjunct Associate Professor

    Oregon Health and Science University

     

    Janet A. Hindler, MCLS, MT(ASCP)
    Sr. Specialist, Clinical Microbiology
    UCLA Health System

    Learning Objectives:

    ·          List the CLSI standards for antimicrobial susceptibility testing introduced in 2014.

    ·          Discuss strategies for reporting antimicrobial test results to best influence appropriate therapy.

    ·          Describe ways in which the microbiology lab can contribute to antibiotic stewardship and confront contemporary antimicrobial reporting and antimicrobial prescribing challenges.  

     

    Can’t make the live webinar?

    This webinar is scheduled to be available On-Demand at http://www.proce.com/AntimicrobialTesting
    beginning September 24, 2014.

     

    This CE activity is co-sponsored by ProCE, Inc., CLSI, and SIDP. ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-14-162-L01-P has been assigned to this knowledge-based live CE activity (initial release date 8-27-14). This CE activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers. Successful completion of an online post-test and evaluation at www.ProCE.com is required to receive CE credit. No partial credit will be given.

     

    Funding:
    This activity is self-funded by SIDP, CLSI, and members of ACCP ID PRN and ACCP CRIT PRN.

     

    Register Now!

     

     


     

     

     

  • 01 Aug 2014 12:15 PM | Christopher McCoy (Administrator)

    The Society of Infectious Diseases Pharmacists

    2014 Call for Grant Applications to Fund Two

    Infectious Diseases Pharmacotherapy Young Investigator

     Research Awards

     

    The Society of Infectious Diseases Pharmacists (SIDP) is a dynamic association of health professionals dedicated to promoting the appropriate use of antimicrobials.  SIDP is committed to excellence in infectious diseases education, pharmacotherapy, and research.  One of the missions of SIDP is to promote research endeavors.

     

    SIDP is soliciting ID pharmacotherapy research proposals from SIDP members who qualify as young investigators [£5 years from completion of their terminal training (e.g., residency, fellowship, graduate degree)].  The primary purpose of the research award is to provide funding for research projects that will contribute to the further development of the principal investigator’s research career and improve their competitiveness for future extramural funding.  Favorable consideration will be given to research proposals which focus on current pharmacotherapy issues surrounding the prevention and management of infectious diseases.

     

    Proposals should be converted to a single PDF file adhering to the format described above. The PDF file of the proposal is then electronically submitted to both Stephanie Bulak (sbulak@eami.com) and the Chair of the Research Committee, David E. Nix (nix@pharmacy.arizona.edu).

     

    Proposals must be submitted online no later than 5PM E.S.T. on Friday, August 8, 2014. 

     

    For further details, click here.

  • 23 Jul 2014 4:39 PM | Christopher McCoy (Administrator)

    The results of the election are in: Congratulations to the newly elected SIDP Board Members for 2014-15

    President-Elect

    Jason Gallagher

    Secretary/Treasurer

    Sandy Estrada

    Board member-at-large

    Craig Martin

  • 17 Jul 2014 11:43 AM | Christopher McCoy (Administrator)

    Join us atop the skyline at the R2L restaurant in Center City Philadelphia at 

    50 S. 16th Street, 37th Floor, Philadelphia, PA 6:00 to 8:00 pm. Details forthcoming.
  • 17 Jul 2014 11:41 AM | Christopher McCoy (Administrator)

    Join us for our annual meeting in Washington, DC on September 5th at the Mandarin Oriental Hotel.  The business meeting and CE programming is planned to begin at noon with a reception to follow at 6:30pm. The fee for non-members/non-healthcare professionals including guests is $85 for the daytime meeting and evening reception or $50 for the evening reception alone.  Payments are accepted online via PayPal or credit card.

    The agenda for the daytime meeting and CE information can be seen here. Final program logistics and details are coming.  Go to the events page for registration.
  • 11 Jul 2014 3:05 PM | Christopher McCoy (Administrator)

    “Antimicrobial Guidelines: Filling the Gaps - Addressing the Outliers”, see our events page for more details and sign on to the ICAAC registration page to register.

  • 26 Jun 2014 2:43 PM | Christopher McCoy (Administrator)

    Visit our continuing education page to view this new program developed by

    VemcoMedEd and Center for Independent Healthcare Education as a CME/CPE-certified 0.2 CEU credited Online Activity: Bacterial Infections in Patients with Cancer: New Challenges,  New Opportunities, supported by an educational grant from Cubist Pharmaceuticals.

Membership gives you more

  • Access exclusive opportunities
  • Connect with colleagues
  • Attend networking events

JOIN TODAY


Society of Infectious Diseases Pharmacists • 823 Congress Avenue, Suite 230 Austin, Texas 78701 • (512) 328-8632


Powered by Wild Apricot Membership Software